Solifenacinesuccinaat/Tamsulosinehydrochloride Synthon Synthon

Solifenacinesuccinaat/Tamsulosinehydrochloride Synthon combines two active ingredients for bladder control support. This oral medication is used to treat symptoms of overactive bladder and benign prostatic hyperplasia. It is manufactured by Synthon Bv and sourced from the EU. Suitable for adults seeking relief from urinary urgency and frequency.

This combination medication is commonly prescribed to address symptoms associated with overactive bladder, such as frequent urination, urgency, and incontinence. It may also be used to relieve urinary symptoms linked to benign prostatic hyperplasia, including difficulty urinating and frequent nighttime urination. The dual-action formula targets bladder muscle relaxation and prostate smooth muscle relaxation for improved urinary flow and control.

Users may experience reduced urgency to urinate and fewer instances of bladder contractions. Some individuals report improved ability to delay urination and a decrease in nighttime bathroom visits. The medication works gradually, with noticeable effects typically developing over several weeks of consistent use. Individual responses may vary based on body chemistry and condition severity.

Store this medication in a cool, dry place away from direct sunlight and out of reach of children. Keep the original packaging to protect it from moisture. If you experience severe dizziness or fainting, consult a healthcare provider promptly. Inform your doctor of any pre-existing conditions, especially heart, liver, or kidney issues, before starting this medication.

This medication may interact with other drugs that affect heart rhythm or blood pressure, including certain antidepressants and antihistamines. Alcohol and sedatives can enhance drowsiness, so use caution when combining them. CYP3A4 inhibitors, such as ketoconazole or ritonavir, may increase the levels of solifenacin in your system. Always disclose all medications and supplements to your healthcare provider.